These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24747591)
1. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas. Zhang C; Yao C; Li H; Wang G; He X Int J Mol Sci; 2014 Apr; 15(4):6544-55. PubMed ID: 24747591 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Zhang C; Yao C; Li H; Wang G; He X Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799 [TBL] [Abstract][Full Text] [Related]
3. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer. Ge J; Chen Z; Li R; Lu T; Xiao G Cancer Cell Int; 2014; 14(1):128. PubMed ID: 25525411 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas. Hong Q; Fang J; Pang Y; Zheng J Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607 [TBL] [Abstract][Full Text] [Related]
7. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma. Cai H; Lin L; Cai H; Tang M; Wang Z Int J Mol Sci; 2014 Jan; 15(1):560-73. PubMed ID: 24398981 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Tsai MM; Wang CS; Tsai CY; Chen CY; Chi HC; Tseng YH; Chung PJ; Lin YH; Chung IH; Chen CY; Lin KH Cancer Lett; 2014 Sep; 351(2):222-31. PubMed ID: 24933454 [TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2. Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma. Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741 [TBL] [Abstract][Full Text] [Related]
12. Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Lu YC; Chang JT; Huang YC; Huang CC; Chen WH; Lee LY; Huang BS; Chen YJ; Li HF; Cheng AJ Clin Biochem; 2015 Feb; 48(3):115-21. PubMed ID: 25485932 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma. Zou P; Ding J; Fu S Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma. Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-542-3p as a prognostic biomarker in osteosarcoma. Li Q; Song S; Ni G; Li Y; Wang X Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020 [TBL] [Abstract][Full Text] [Related]
17. MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma. Wang X; Zhang L; Zhang X; Xing C; Liu R; Zhang F Cancer Biomark; 2020; 29(2):291-298. PubMed ID: 32675397 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Shang Y; Wang LQ; Guo QY; Shi TL Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma. Mu Y; Zhang H; Che L; Li K Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761 [TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]